


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-5.65%
+0.64%
+3.34%
+0.45%
XRAY
DENTSPLY SIRONA
$10.58
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value
Chart
$13.07 (-19.05%)
$14.3 (-26.01%)
$16.67 (-36.53%)
$19.08 (-44.55%)
XRAY has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

XRAY overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value
![]()
XRAY Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
XRAY Street Sentiment is bullish but have mixed views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is XRAY current stock price?
What are XRAY stock strengths?
What is XRAY Risk Level?
What is XRAY market cap and volume?
What is XRAY current Stock IQ?
Should I buy XRAY stock right now?
Is XRAY a Strong Buy right now?
What does a 'Strong Buy' rating mean for XRAY?
What does a 'Strong Sell' rating mean for XRAY?
What factors influence XRAY's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-5.65%
+0.64%
+3.34%
+0.45%
XRAY
DENTSPLY SIRONA
Current Price
$10.58
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Trading below its fair value

Chart
$13.07 (-19.05%)
$14.3 (-26.01%)
$16.67 (-36.53%)
$19.08 (-44.55%)
XRAY Analysts Opinion
XRAY Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate

Reported a strong earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value
![]()
XRAY Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
XRAY Street Sentiment is bullish but have mixed views on the near-term outlook
XRAY has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk

Average key support and resistance price levels.
XRAY Latest Analysis
With Ongoing Struggles Dentsply Sirona Launches Another Turnaround Effort.
Tue Nov 11, 2025
Barrington Research Maintains DENTSPLY SIRONA (XRAY) Outperform Recommendation. Fintel reports that on November 10 2025 Barrington Research maintained coverage of DENTSPLY SIRONA (NasdaqGS:XRAY) with a Outperform recommendation. Analyst Price Forecast Suggests 47.14% Upside
Tue Nov 11, 2025
Dentsply Sirona Stock Sinks On Missed Expectations Lowered 2025 Guidance. CEO Unveils Return-To-Growth Plan. ) stock is trading lower on Thursday after weaker-than-expected third-quarter . . XRAY shares are approaching critical lows. Adjusted earnings came in at 37 cents down from 50 cents a year ago beating the . The decline was attributed to sales mix tariffs and a higher tax rate.The dental equipment company reported sales of $904 million down 5% year over year beating the consensus of $896.7
Thu Nov 6, 2025
DENTSPLY SIRONA Enters Oversold Territory. The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks according to a proprietary formula designed to identify those stocks that combine two important characteristics &mdash. strong fundamentals and a valuation that looks inexpensive.
Thu Nov 6, 2025
XRAY Stock Declines on Q3 Earnings Miss & Lower 2025 EPS View. DENTSPLY SIRONA shares drop as Q3 earnings miss estimates and 2025 EPS guidance is cut amid segment weakness.
Thu Nov 6, 2025
Dentsply Sirona price target lowered to $13 at Stifel on guidance cut.
Thu Nov 6, 2025
Dentsply Sirona Non-GAAP EPS of $0.37 misses by $0.08 revenue of $904M beats by $6.27M.
Thu Nov 6, 2025
Dentsply Sirona Reports Third Quarter 2025 Results. CHARLOTTE N.C. Nov. 06 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (Dentsply Sirona or the Company) (Nasdaq: XRAY) today announced its financial results for the third quarter of 2025 and introduced its Return-to-Growth action plan a comprehensive strategy to improve performance and position the Company for sustained profitable growth over the next 24 months.
Thu Nov 6, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
XRAY Stock trends
XRAY Stock performance
XRAY Stock analysis
XRAY investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.